These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 10794090)

  • 1. The risk of blood-borne Creutzfeldt--Jakob disease.
    Brown P
    Dev Biol (Basel); 2000; 102():53-9. PubMed ID: 10794090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variant Creutzfeldt-Jakob disease: risk of transmission by blood and blood products.
    Ironside JW; Head MW
    Haemophilia; 2004 Oct; 10 Suppl 4():64-9. PubMed ID: 15479374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Creutzfeldt-Jakob disease: reflections on the risk from blood product therapy.
    Brown P
    Haemophilia; 2007 Dec; 13 Suppl 5():33-40. PubMed ID: 18078395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Creutzfeldt-Jakob disease: current U.S. policy to further reduce the possible risk of transmission by transfusion.
    Menache D; O'Malley JP
    Biologicals; 1996 Sep; 24(3):277-83. PubMed ID: 8978926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variant Creutzfeldt-Jakob disease and prions in the blood supply.
    Rohwer RG; Drohan W
    Clin Adv Hematol Oncol; 2004 Feb; 2(2):84, 87, 131. PubMed ID: 16163166
    [No Abstract]   [Full Text] [Related]  

  • 6. Further studies of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with an explanation of why blood components do not transmit Creutzfeldt-Jakob disease in humans.
    Brown P; Cervenáková L; McShane LM; Barber P; Rubenstein R; Drohan WN
    Transfusion; 1999; 39(11-12):1169-78. PubMed ID: 10604242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Creutzfeldt-Jakob disease and blood transfusion.
    Fernandez Lopez MJ; Van Everbroeck B; Pals P; Martin JJ; Cras P
    Acta Neurol Belg; 1998 Sep; 98(3):247-51. PubMed ID: 9801705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prions and transfusion medicine.
    Budka H
    Vox Sang; 2000; 78 Suppl 2():231-8. PubMed ID: 10938959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Infectious prion disease: CJD with dura mater transplantation].
    Sato T
    Rinsho Shinkeigaku; 2003 Nov; 43(11):870-2. PubMed ID: 15152489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Creutzfeldt-Jakob disease associated with cadaveric dura mater grafts -- Japan, January 1979-May 1996.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1997 Nov; 46(45):1066-9. PubMed ID: 9385874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Creutzfeld-Jacob disease and blood product recalls.
    Colvin R; Dubin C; Haas G
    Common Factor; 1994 Apr; (no 10):23. PubMed ID: 11362357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Risk factors for sporadic Creutzfeldt-Jakob disease].
    Kittner C; Heinemann U; Zerr I
    Dtsch Med Wochenschr; 2009 Jul; 134(27):1429-35. PubMed ID: 19551608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood-transmitted prions and variant Creutzfeldt-Jakob disease.
    Grady GF; Vyas GN
    Biologicals; 2007 Apr; 35(2):75-7. PubMed ID: 17317213
    [No Abstract]   [Full Text] [Related]  

  • 14. Tissue safety in view of CJD and variant CJD.
    Pauli G
    Cell Tissue Bank; 2005; 6(3):191-200. PubMed ID: 16151959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue classification for the epidemiological assessment of surgical transmission of sporadic Creutzfeldt-Jakob disease. A proposal on hypothetical risk levels.
    Rábano A; de Pedro-Cuesta J; Mølbak K; Siden A; Calero M; Laursen H;
    BMC Public Health; 2005 Jan; 5():9. PubMed ID: 15667663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Managing the risk of transmission of variant Creutzfeldt Jakob disease by blood products.
    Ludlam CA; Turner ML
    Br J Haematol; 2006 Jan; 132(1):13-24. PubMed ID: 16371015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Creutzfeldt-Jakob disease: recommendations for disinfection and sterilization.
    Rutala WA; Weber DJ
    Clin Infect Dis; 2001 May; 32(9):1348-56. PubMed ID: 11303271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methods to minimize the risks of Creutzfeldt-Jakob disease transmission by surgical procedures: where to set the standard?
    Sutton JM; Dickinson J; Walker JT; Raven ND
    Clin Infect Dis; 2006 Sep; 43(6):757-64. PubMed ID: 16912952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iatrogenic Creutzfeldt-Jakob disease: the waning of an era.
    Brown P; Brandel JP; Preece M; Sato T
    Neurology; 2006 Aug; 67(3):389-93. PubMed ID: 16855204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfusion transmission of human prion diseases.
    Zou S; Fang CT; Schonberger LB
    Transfus Med Rev; 2008 Jan; 22(1):58-69. PubMed ID: 18063192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.